NATCO Pharmaceuticals logo

NATCO Pharmaceuticals

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series D

eGenesis logo
eGenesis

Biotechnology

Lux Capital logo
Parkwood Corporation logo
NATCO Pharmaceuticals logo
Khosla Ventures logo
Fresenius Medical Care Ventures logo
Farallon Capital Management logo
Eisai Innovation logo
DaVita logo

eGenesis is a biotechnology company developing genetically engineered organs to address the global organ shortage, with a focus on advancing their lead product candidate for kidney transplants.

Series D
$191M
09/04/2024
Article